Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dova Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dova Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Dova Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is DOVA. The reporting company's CIK number is 1685071.
The total value of stock buying since 2005 is $5,926,430.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-08-16||Pbm Capital Investments, Llc (10% Owner)||Buy||5,000||25.77||128,835|
|2017-08-15||Pbm Capital Investments, Llc (10% Owner)||Buy||20,870||21.77||454,444|
|2017-08-15||Goldman Steven M. (Director)||Buy||20,169||22.20||447,751|
|2017-07-05||Laliberte Kevin (Sr. VP, Product Development)||Buy||6,200||17.00||105,400|
|2017-07-05||Sapir Alex (President & CEO)||Buy||20,100||17.00||341,700|
|2017-07-05||Pbm Capital Investments, Llc (10% Owner)||Buy||150,000||17.00||2,550,000|
|2017-07-05||Goldman Steven M. (Director)||Buy||72,000||18.12||1,305,000|
|2017-07-05||Allen Lee F Md Phd (Chief Medical Officer)||Buy||3,500||17.00||59,500|
|2017-07-05||Jeffs Roger (Director)||Buy||31,400||17.00||533,800|
Insider trading activities including stock purchases, stock sales, and option exercises of DOVA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dova Pharmaceuticals, Inc. (symbol DOVA, CIK number 1685071) see the Securities and Exchange Commission (SEC) website.